-transparent.png){kind=logo}
A total of 113 patients with recurrent genital herpes were enrolled in a multicentre cross-over study. Two consecutive recurrences were treated with either oral acyclovir 200 mg or matching placebo five times daily for five days. Acyclovir significantly reduced the time to crusting and healing and the duration of new lesions and symptoms. Acyclovir was not found to have any clinically significant effect on the haematological or biochemical parameters measured, or to have caused adverse events and was well tolerated. Early self-initiated treatment may abort a recurrent attack of genital herpes without progression to the ulcerative or crusting stage.
Related Publications
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
April 1984,
JAMA,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
February 1990,
The Journal of infectious diseases,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
July 1982,
The American journal of medicine,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
May 1985,
The Medical letter on drugs and therapeutics,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
April 1990,
Genitourinary medicine,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
January 1983,
Transactions of the Association of American Physicians,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
January 1985,
Scandinavian journal of infectious diseases. Supplementum,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
January 1985,
Scandinavian journal of infectious diseases. Supplementum,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
January 1986,
Dermatologica,
M Ruhnek-Forsbeck, and
E Sandström, and
B Andersson, and
G Eriksson, and
K Hersle, and
G B Lövhagen, and
H Mobacken, and
L Hillström, and
L Svensson
July 1984,
Lancet (London, England),
